HOME  |  CONTACT  |  SITEMAP   
Home > 교실소개 > 임상의학 > 교수진 명단

| 교수진 명단



  • 문덕복 교수

    외과학

    패스워드가 일치하지 않습니다.

    전공분야

    간이식, 간담도외과

    소속연구단

    관련/관심분야

        데이터가 없습니다.

    주요논문

    1. Application of Proximal Splenic Vein Embolization to Interrupt Complicated Large Splenorenal Shunts in Adult Living Donor Liver Transplantation [ ANNALS OF SURGERY ] - 2022.12.01
    2. How to reduce and manage the hepatic arterial complications in living and deceased donor liver transplantation? [ HEPATOBILIARY SURGERY AND NUTRITION ] - 2021.04.10
    3. Preoperative prediction score of hepatocellular carcinoma recurrence in living donor liver transplantation: Validation of SNAPP score developed at Asan Medical Center [ AMERICAN JOURNAL OF TRANSPLANTATION ] - 2021.02.01
    4. Over 500 Liver Transplants Including More Than 400 Living-Donor Liver Transplants in 2019 at Asan Medical Center [ TRANSPLANTATION PROCEEDINGS ] - 2021.02.01
    5. Adult Living Donor Liver Transplantation for Acute-on-Chronic Liver Failure in High-Model for End-Stage Liver Disease Score Patients [ AMERICAN JOURNAL OF TRANSPLANTATION ] - 2017.07.01
    6. Portal vein stenting as a significant risk factor for biliary stricture in adult living donor liver transplantation [ Hepatobiliary & Pancreatic Diseases International ] - 2016.10.01
    7. Restoration of portal flow using a pericholedochal varix in adult living donor liver transplantation for patients with total portosplenomesenteric thrombosis [ LIVER TRANSPLANTATION ] - 2014.05.01
    8. Section 6. Management of extensive nontumorous portalvein thrombosis in adult living donor liver transplantation [ TRANSPLANTATION ] - 2014.04.27
    9. Renoportal Anastomosis for dual-graft living donor liver transplantation using an artificial graft and a left renal vein-connected inferior vena cava cuff [ LIVER TRANSPLANTATION ] - 2014.03.01

    연구과제 수주실적

    1. 일차 생체 간이식 환자를 대상으로 써티로벨(R)정과 Calcineurin Inhibitor 병용투여군과 Mycophenolate Mofetil과 Calcineurin Inhibitor 병용투여군의 유효성 및 안전성을 비교 평가하기 위한 단일기관, 공개, 무작위배정, 제 4상 임상시험 (ASTRO study) - 2022.05.23 ~ 2025.06.30

    특허/기술이전실적

      데이터가 없습니다.

    국내외 경력

          데이터가 없습니다.

     공지